Explore the latest in law and medicine, including malpractice, regulation, and legislation affecting public health and clinical practice.
This Medical News article discusses a bill introduced in Idaho that would ban administering mRNA vaccines.
This population epidemiology study assesses the association of California’s 2013 implementation of the Insurance Gender Nondiscrimination Act and utilization of gender-affirming surgery among California residents, compared with residents of the control states of Washington and Arizona.
This Viewpoint discusses a pending US Supreme Court case to determine the extent to which people who identify as LGBTQ+ are protected under state antidiscrimination laws in the commercial marketplace.
This cross-sectional study collects data on US prison policies concerning organ donation by incarcerated individuals.
This interrupted time-series analysis uses data from the National Inpatient Sample and the Acute Liver Failure Study Group to assess the odds of hospitalization and the proportion of acute liver failure cases with acetaminophen and opioid toxicity prior to and after the US Food and Drug Administration mandate to limit acetaminophen (paracetamol) to 325 mg/tablet in combination acetaminophen and opioid medications.
This Viewpoint discusses the goals of the inaugural National Drug Control Strategy, which as the ambitious agenda of emphasizing harm reduction practices, medications for treating opioid use disorder, and criminal justice reform, as well as supporting long-term recovery and interrupting illicit drug trafficking.
This case-control study uses data from the 2009-2017 Youth Risk Behavior Survey to explore the association between antibullying law adoption and changes in suicidal behaviors among lesbian, gay, bisexual, and questioning youth.
This cross-sectional study examines trends in abortion in Georgia from 2007 to 2017 by weeks of gestation and estimates the proportion of abortions that will remain legal in Georgia after the passage of House Bill 481, a restrictive abortion law, goes into effect by patient race, age, and educational level.
This Viewpoint discusses potential consequences that the US Supreme Court ruling in Dobbs v Jackson Women’s Health Organization may have for patient outcomes, public health, training and legal challenges for health care professionals, and the patient-practitioner relationship.
This cross-sectional study examines the association of expansion of Supplemental Nutrition Assistance Program (SNAP) eligibility by US states with changes in the rates of child protective services–investigated reports for suspected neglect and physical abuse of children.
This observational study assesses the role of medical cannabis law and recreational cannabis law enactment in diagnosed cannabis use disorder prevalence among Veterans Health Administration patients by using yearly electronic medical record data from 2005 to 2019.
This Viewpoint suggests that professional societies should continue to advocate for equitable access for patients to all necessary medical care including abortion care.
This Viewpoint discusses how to support patient and clinician safety regarding extreme online threats to gender-affirming care.
This cross-sectional study compares the number of incarceration-related projects funded at the National Institutes of Health, US Department of Justice, and National Science Foundation compared with other social and behavioral risk–related projects.
This cross-sectional study examines the characteristics of prior authorization policies for new drugs in Medicare Part D to understand whether they are consistent with US Food and Drug Administration indications.
This cross-sectional study evaluates patient exposure to oncology drugs withdrawn from the US Food and Drug Administration (FDA) Accelerated Approval program.
This Viewpoint reviews California’s recently proposed CalRx initiative to manufacture biosimilar insulin, highlights challenges facing the initiative, and suggests ways in which, if successful, the initiative could serve as a model for state-managed development of drugs other than insulin, reduce drug prices, and provide other benefits.
Customize your JAMA Network experience by selecting one or more topics from the list below.